Stocks to sell

What’s next for Castor Maritime (NASDAQ:CTRM) stock? The dry-bulk shipper has soared nearly five-fold since January. Even after pulling back more than 50% off its highs ($1.95 per share) in recent weeks. Source: Pavel Kapysh / Shutterstock.com News of the company’s expansion may be playing a role in its upward surge, but maybe its sudden

Not much changed in the last few months preceding Bumble’s (NASDAQ:BMBL) initial public offering. Last September, Bloomberg News reported a valuation of $6 billion to $8 billion. So, after Bumble stock started trading in early February, valuations have been in line with insider expectations. Source: XanderSt / Shutterstock.com What is the play with trading Bumble

Investors in Zomedica (NYSE:ZOM) have been taken on quite the wild ride this year. ZOM stock is up nearly 1,000% year-to-date, and over 30% this past week alone. Source: didesign021 / Shutterstock.com Why the buzz? There are a few key things going on with this stock right now. So sorting them out is a priority. Let’s dive

Back in mid-February, those buying the dip in GameStop (NYSE:GME) stock may have seemed a bit foolhardy. But, with the king of all meme stocks going on a second Reddit rally, retail traders have again beaten Wall Street’s so-called smart money at their own game. Source: Shutterstock / mundissima With those active on Reddit’s WallStreetBets

Since its launch at the beginning of March, the VanEck Vectors Social Sentiment ETF (NYSEARCA:BUZZ) has attracted more than its share of enthusiasm. Inflows into the BUZZ ETF (exchange-traded fund) have simply been huge. Source: Shutterstock In fact, BUZZ attracted more than $280 million in capital right out of the gate. As of Mar. 17,

Canadian marijuana group Sundial Growers (NASDAQ:SNDL) has recently been in the limelight. SNDL stock, which started 2021 around 50 cents, saw a 52-week high of $3.96 on Feb. 11. Let’s delve into the weeds and take a closer look at the company.  Source: Shutterstock Currently, shares are hovering around $1.60. By comparison, the ETFMG Alternative Harvest ETF (NYSEARCA:MJ),

With investors excited about U.S. federal pot legalization, major cannabis equities remain elevated. That includes Aphria (NASDAQ:APHA) stock. But, while the Canada-based cannabis company offers exposure to possible changes in U.S. marijuana law, it may not be the best way to wager on it. Source: Shutterstock Blame it on its pending merger with Tilray (NASDAQ:TLRY).

Let’s establish the fact that I am not a hater of Starbucks (NASDAQ:SBUX) stock. In fact, I was a fan when it mattered most. When the going got tough last year, I saw past the pandemic problems. I supported SBUX stock with my article March 17. Source: Natee Meepian / Shutterstock.com That was one day

As the most dominant online advertising player in the world, Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) calls the shots. When Google says the rules of the game change, they change. The company’s recent move to end its behavioral targeting policies have been welcome news for privacy advocates. In the eyes of many consumers, this move was a long time

Over the last six weeks — as interest rates have risen and the economy has moved closer to normalcy — there has been a great deal of concern on Wall Street about overvalued stocks. In many ways, despite the correction of growth stocks, I’m more upbeat on those equities as a whole than other pundits.

As cryptocurrencies soar, investors are turning toward mining plays like SOS Limited (NYSE:SOS) stock. It’s a questionable, and even dangerous, strategy. Source: Mark Agnor / Shutterstock.com That’s not because cryptocurrencies are due for a collapse. I don’t believe that at all. In fact, I believe the opposite. I’m a long-time crypto bull. In theory, the

Since the its initial public offering (IPO) in late September, the shares of Palantir Technologies (NYSE:PLTR) have logged impressive gains, up about 190%. This has put the market capitalization at $48.7 billion. Although, as has been the case with other hot tech operators lately, PLTR stock has come under pressure. The price has gone from

Marijuana stocks have cooled off in recent weeks. Organigram Holdings (NASDAQ:OGI) stock was once a “can’t lose” bet, but it has turned out to be a volatile one with plenty of risk. Source: Shutterstock Let’s examine the company-specific and sector-specific concerns driving this volatility. Lack of U.S. Presence Is a Real Issue for OGI Stock

Perhaps one of my most glaring criticisms from an editing standpoint is that I write long introductory paragraphs. So, for those who have suffered from my loquaciousness, here’s perhaps my shortest lede ever. It may be time to rethink Nio (NYSE:NIO), and therefore to sell NIO stock. Before I get into it, let’s discuss some

Car stocks, especially shares of electric vehicles (EVs), have turbocharged portfolios in the past year. Meanwhile, the auto industry — which increasingly relies on semiconductors — has been in the limelight. However, due to the current chip shortage, many car makers have announced they would be temporarily halting production. As a result, car stocks have

Organigram Holdings (NASDAQ:OGI) is just another one of the many Canadian cannabis companies struggling to get profitable. As a result, OGI stock is down 26% from its high of $6 on Feb. 10. Good luck with this company getting profitable enough to justify that price again. Source: Shutterstock In fact, in the past year OGI

ChargePoint Holdings (NYSE:CHPT), an EV charging company that has come to market via the Switchback Energy Acquisition Corp. (NYSE:SBE) SPAC, has been a volatile. Indeed, CHPT stock has fallen approximately 40% from its 52-week high late last year. Source: Michael Vi / Shutterstock.com There are a couple of factors driving shares lower. Among these are the rise

iBio (NYSEAMERICAN:IBIO) stock is up 12% in the past year and up 74% in the year-to-date period. However, since I last wrote about IBIO stock on Nov. 20, the stock is mostly flat, including two big drops,lending credence to my concerns. Source: Shutterstock My worry at the time was that the company would continue to issue

Walmart (NYSE:WMT) knows how to wow the markets. It told the world and analysts during its February 18 earnings release that it expects “low single digits” in sales growth. Meaning 1% or 2%. As a result, don’t expect WMT stock to take off this year like a thunderbolt. Source: Ken Wolter / Shutterstock.com Moreover, Walmart’s

In hindsight, CRISPR Therapeutics (NASDAQ:CRSP) represented a once-in-a-blue-moon opportunity during the March doldrums of last year. For a brief moment, CRSP stock slipped below $40 as the world turned its eyes on the rapidly escalating novel coronavirus pandemic. However, shares didn’t stay deflated for long as they continued to march steadily higher despite the surrounding